Literature DB >> 7795650

The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice.

K A Frazer1, G Narla, J L Zhang, E M Rubin.   

Abstract

High plasma concentrations of apolipoprotein (a) (apo(a)) have been implicated as a major independent risk factor for atherosclerosis in humans. Apo(a) is a large, evolutionarily new gene (present primarily in primates) for which considerable controversy exists concerning the factors that regulate its expression. To investigate the in vivo regulation of apo(a), we have created several lines of YAC transgenic mice containing a 110-kb human apo(a) gene surrounded by greater than 60 kb of 5' and 3' flanking DNA. Studies in humans have suggested that acute-phase inducers increase and sex steroids decrease apo(a) concentrations, but these results are controversial. Analysis of the YAC transgenic mice conclusively supports the hypothesized role of sex steroids and refutes the suggested role of acute-phase inducers in regulating the apo(a) gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795650     DOI: 10.1038/ng0495-424

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  19 in total

1.  Metrics of sequence constraint overlook regulatory sequences in an exhaustive analysis at phox2b.

Authors:  David M McGaughey; Ryan M Vinton; Jimmy Huynh; Amr Al-Saif; Michael A Beer; Andrew S McCallion
Journal:  Genome Res       Date:  2007-12-10       Impact factor: 9.043

2.  Position-independent expression of a human nerve growth factor-luciferase reporter gene cloned on a yeast artificial chromosome vector.

Authors:  F A Asselbergs; R Grossenbacher; R Ortmann; B Hengerer; G K McMaster; E Sutter; R Widmer; F Buxton
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

3.  A dicistronic construct allows easy detection of human CFTR expression from YAC DNA in human cells.

Authors:  G Vassaux; C Huxley
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

Review 4.  Size matters: use of YACs, BACs and PACs in transgenic animals.

Authors:  P Giraldo; L Montoliu
Journal:  Transgenic Res       Date:  2001-04       Impact factor: 2.788

Review 5.  Biological insights through genomics: mouse to man.

Authors:  E M Rubin; G S Barsh
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

6.  Farnesoid X receptor represses hepatic human APOA gene expression.

Authors:  Indumathi Chennamsetty; Thierry Claudel; Karam M Kostner; Anna Baghdasaryan; Dagmar Kratky; Sanja Levak-Frank; Sasa Frank; Frank J Gonzalez; Michael Trauner; Gert M Kostner
Journal:  J Clin Invest       Date:  2011-08-01       Impact factor: 14.808

7.  Nicotinic acid inhibits hepatic APOA gene expression: studies in humans and in transgenic mice.

Authors:  Indumathi Chennamsetty; Karam M Kostner; Thierry Claudel; Manjula Vinod; Sasa Frank; Thomas S Weiss; Michael Trauner; Gerhard M Kostner
Journal:  J Lipid Res       Date:  2012-08-28       Impact factor: 5.922

8.  Lipoprotein(a) accelerates atherosclerosis in uremic mice.

Authors:  Tanja X Pedersen; Sally P McCormick; Sotirios Tsimikas; Susanne Bro; Lars B Nielsen
Journal:  J Lipid Res       Date:  2010-06-28       Impact factor: 5.922

9.  Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits.

Authors:  Tomonaga Ichikawa; Hiroyuki Unoki; Huijun Sun; Hiroaki Shimoyamada; Santica Marcovina; Hisataka Shikama; Teruo Watanabe; Jianglin Fan
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 10.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.